Sandford D. Smith
2015
In 2015, Sandford D. Smith earned a total compensation of $1.1M as former interim Chief Executive Officer at Aegerion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $136,538 |
|---|---|
| Option Awards | $418,368 |
| Salary | $275,167 |
| Stock Awards | $243,461 |
| Other | $70,230 |
| Total | $1,143,764 |
Smith received $418.4K in option awards, accounting for 37% of the total pay in 2015.
Smith also received $136.5K in non-equity incentive plan, $275.2K in salary, $243.5K in stock awards and $70.2K in other compensation.
Rankings
In 2015, Sandford D. Smith's compensation ranked 7,292nd out of 13,638 executives tracked by ExecPay. In other words, Smith earned more than 46.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,292 out of 13,638 | 47th |
Division Manufacturing | 2,744 out of 5,190 | 47th |
Major group Chemicals And Allied Products | 984 out of 1,854 | 47th |
Industry group Drugs | 790 out of 1,528 | 48th |
Industry Pharmaceutical Preparations | 618 out of 1,182 | 48th |
Source: SEC filing on April 29, 2016.
Smith's colleagues
We found seven more compensation records of executives who worked with Sandford D. Smith at Aegerion Pharmaceuticals in 2015.
2015
Marc Beer
Aegerion Pharmaceuticals
Chief Executive Officer
2015
Gregory Perry
Aegerion Pharmaceuticals
Chief Financial & Administration Officer
2015
Mark Sumeray
Aegerion Pharmaceuticals
Chief Medical Officer
2015
Martha Carter
Aegerion Pharmaceuticals
Chief Regulatory Officer
2015
Mary Weger
Aegerion Pharmaceuticals
former Chief Performance Officer
2015
Mark Fitzpatrick
Aegerion Pharmaceuticals
Chief Financial Officer
2015
David Aubuchon
Aegerion Pharmaceuticals